Literature DB >> 15576033

Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods.

Eric S Manas1, Zhang B Xu, Rayomand J Unwalla, William S Somers.   

Abstract

We present X-ray crystallographic and molecular modeling studies of estrogen receptors-alpha and -beta complexed with the estrogen receptor-beta-selective phytoestrogen genistein, and coactivator-derived NR box peptides containing an LXXLL motif. We demonstrate that the ligand binding mode is essentially identical when genistein is bound to both isoforms, despite the considerably weaker affinity of this ligand for estrogen receptor-alpha. In addition, we examine subtle differences between binding site residues, providing an explanation for why genistein is modestly selective for the beta isoform. To this end, we also present the results of quantum chemical studies and thermodynamic arguments that yield insight to the nature of the interactions leading to estrogen receptor-beta selectivity. The importance of our analysis to structure-based drug design is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576033     DOI: 10.1016/j.str.2004.09.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  37 in total

1.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Interaction force diagrams: new insight into ligand-receptor binding.

Authors:  Hooman Shadnia; James S Wright; James M Anderson
Journal:  J Comput Aided Mol Des       Date:  2008-11-07       Impact factor: 3.686

Review 3.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

Review 4.  The pros and cons of phytoestrogens.

Authors:  Heather B Patisaul; Wendy Jefferson
Journal:  Front Neuroendocrinol       Date:  2010-03-27       Impact factor: 8.606

Review 5.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

Review 6.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.

Authors:  Erin K Shanle; Wei Xu
Journal:  Chem Res Toxicol       Date:  2010-11-05       Impact factor: 3.739

7.  Computational polypharmacology analysis of the heat shock protein 90 interactome.

Authors:  Andrew Anighoro; Dagmar Stumpfe; Kathrin Heikamp; Kristin Beebe; Leonard M Neckers; Jürgen Bajorath; Giulio Rastelli
Journal:  J Chem Inf Model       Date:  2015-02-23       Impact factor: 4.956

8.  Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors.

Authors:  Cédric Bovet; Arno Wortmann; Sylvia Eiler; Florence Granger; Marc Ruff; Bertran Gerrits; Dino Moras; Renato Zenobi
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

9.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

10.  Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells.

Authors:  Danyetta D Davis; Edgar S Díaz-Cruz; Serena Landini; Young-Woo Kim; Robert W Brueggemeier
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.